Les voies de la douleur

The descending paths of pain

Nov 09, 2020

Part 3 - Neuro-vascular hypothesis

The descending paths of pain

The descending pain pathways (figure 3) make it possible to modulate the nociceptive response, either by facilitating it, which ultimately contributes to a chronicization of the pain, or by inhibiting it. The origin of this modulation can occur at the segmental and supra-segmental level. Several human neuroimaging studies have demonstrated in migraine an alteration in the activity of suprasegmental structures involved in this modulation, such as the PAG, the RVM, the LC or the hypothalamus. (Afridi et al. 2005; Maniyar et al. 2014; Moulton et al. 2014)

A. The PAG-RVM complex

The PAG and the RVM were the first key structures identified in supra-segmental modulation. These two structures are closely connected. The PAG receives projections from the Sp5C which then projects onto the RVM. The latter in turn sends projections to the Sp5C. (Osipov et al. 2010). RVM modulates nociception bidirectionally and can facilitate or inhibit pain. This capacity for two-way control comes from two classes of neurons called "ON cells" and "OFF cells", and neutral cells, particularly serotonergic ones. OFF cells have been reported to exert an inhibitory effect on nociceptive transmission, while ON cells have a pronociceptive action (Chen et al. 2019).

In rats, the application of an inflammatory soup to the dura mater leads to an increase in the activity of the ON cells of the RVM (Edelmayer et al. 2009). It has also been proven the involvement of OFF cells in the mechanisms of inhibitory pain controls at the level of the NRM (Chebbi et al. 2014). Studies on PAG have shown that injections of opioids or electrical stimulation applied to PAG cause a powerful anti-nociceptive effect in animals (Reynolds 1969; Tsou et al. 1964) as well as in humans (Hosobuchi, et al 1977, Richardson et al 1977). It is now well established that the PAG is a fundamental area in the inhibition of pain by opiates (Ossipov et al. 2010).

In addition, an imaging study showed PAG activation during a placebo effect (Eippert et al. 2009). Similarly, this activation also leads to concomitant activity of the RVM neurons and is associated in rats with a decrease in defensive reflexes (Behbehani et al. 1979). Through their afferent and efferent projections to the LC or the amygdala, PAG and RVM are able to modulate pain, but also sleep-wake cycles, hunger or muscle tone. Thus, there could be a link between the triggering factors of migraine such as hunger or lack of sleep with these structures or with the autonomic signs felt by patients during an attack (fatigue, loss of tone, disgust by food ).

B. The locus coeruleus

The locus coeruleus is a primarily noradrenergic and cholinergic structure that participates in the sleep-wake cycle. The potential role of LC in the pathophysiology of migraine is supported by both preclinical and clinical evidence. It is sensitive to trigemino-vascular activation (Tassorelli et al. 1995; Ter Horst et al. 2001). It is involved in the modulation of many excitatory circuits, plays a role in pain, cognition, stress, and nociception (Schwarz and Luo 2015).

The LC can modulate the neurons of the trigeminal nucleus (Sasa et al. 1973) and its stimulation leads to α2-adrenergic receptor-dependent cerebral hypoperfusion (Goadsby et al. 1989). Stimulation of these receptors is indeed a known trigger of cortical pervasive depression (CPD), the presumed underlying phenomenon of migraine aura (Takano et al. 2007). During wakefulness, the LC receives descending excitatory projections from the hypothalamus that promote its activation (Voisin et al. 2005).

In turn, the LC sends upward noradrenergic projections to the CNS, thalamus, and cortex, as well as downward projections to the CST and spinal cord (Goadsby et al. 2017). As the LC has an essentially diurnal activity and is practically absent during sleep, it is possible that its nocturnal inhibition is at the origin of the alleviation of the pain felt during a migraine attack. Conversely, it may explain why sleep cycle disturbances are a very common factor in patients.

C. The hypothalamus

The hypothalamus also has numerous anatomical connections with pain modulation zones and the trigeminal nucleus (Bartsch et al. 2005; May et al. 2019; Abdallah et al. 2013). A study showed by MRI an activation of the hypothalamus during a migraine attack, as well as a persistent increase in blood flow after the attack and after the administration of sumatriptan (Denuelle et al. 2007).

Orexinergic neurons are present in number in the hypothalamus; they are involved in wakefulness, appetite, pain and some autonomic functions (Holland et al. 2007). This orexinergic system is increasingly studied in the pathophysiology of migraine. Pharmacological blockade of orexin receptors inhibits DCE in rats and also attenuates meningeal arterial vasodilation caused by nociceptive activation of the trigeminal system (Hoffmann et al. 2015). The dopaminergic system also seems to be involved. Indeed, the premonitory symptoms found during migraine attacks such as fatigue, yawning, changes in appetite and nausea involve the activation of the dopaminergic system (Akerman et al. 2007).

Application of dopamine or agonist within the CST inhibits their activation after nociceptive stimulation. The dopaminergic A11 nucleus of the hypothalamus could be the probable source of this dopamine.


(Charbit et al. 2010). Abdallah, Khaled, Alain Artola, Lénaic Monconduit, Radhouane Dallel, and Philippe Luccarini. 2013. “Bilateral Descending Hypothalamic Projections to the Spinal Trigeminal Nucleus Caudalis in Rats.” PLoS ONE 8 (8). https://doi.org/10.1371/journal.pone.0073022. Afridi, Shazia K., Nicola J. Giffin, Holger Kaube, Karl J. Friston, Nick S. Ward, Richard SJ Frackowiak, and Peter J. Goadsby. 2005. “A Positron Emission Tomographic Study in Spontaneous Migraine”. Archives of Neurology 62 (8): 1270. https://doi.org/10.1001/archneur.62.8.1270. Akerman, S, and Pj Goadsby. 2007. “Dopamine and Migraine: Biology and Clinical Implications”. Cephalalgia 27 (11): 1308‑14. https://doi.org/10.1111/j.1468-2982.2007.01478.x. Bartsch, T., MJ Levy, YE Knight, and PJ Goadsby. 2005. “Inhibition of Nociceptive Dural Input in the Trigeminal Nucleus Caudalis by Somatostatin Receptor Blockade in the Posterior Hypothalamus.” Bread 117 (1‑2): 30‑39. https://doi.org/10.1016/j.pain.2005.05.015. Behbehani, MM, and HL Fields. 1979. “Evidence That an Excitatory Connection between the Periaqueductal Gray and Nucleus Raphe Magnus Mediates Stimulation Produced Analgesia”. Brain Research 170 (1): 85-93. https://doi.org/10.1016/0006-8993(79)90942-9. Charbit, Annabelle R, Simon Akerman, and Peter J Goadsby. 2010. "Dopamine: Whatʼs New in Migraine?" ”: Current Opinion in Neurology 23 (3): 275-81. https://doi.org/10.1097/WCO.0b013e3283378d5c. Chebbi, R., N. Boyer, L. Monconduit, A. Artola, P. Luccarini, and R. Dallel. 2014. “The Nucleus Raphe Magnus OFF-Cells Are Involved in Diffuse Noxious Inhibitory Controls.” Experimental Neurology 256 (Jun): 39-45. https://doi.org/10.1016/j.expneurol.2014.03.006. Chen, QiLiang, and Mary M. Heinricher. 2019. “Descending Control Mechanisms and Chronic Pain.” Current Rheumatology Reports 21(5):13. https://doi.org/10.1007/s11926-019-0813-1. Denuelle, Marie, Nelly Fabre, Pierre Payoux, Francois Chollet, and Gilles Geraud. 2007. “Hypothalamic Activation in Spontaneous Migraine Attacks”. Headache: The Journal of Head and Face Pain 0 (0): 070503104159006-??? https://doi.org/10.1111/j.1526-4610.2007.00776.x. Edelmayer, RM, TW Vanderah, L. Majuta, E.-T. Zhang, B. Fioravanti, M. De Felice, JG Chichorro, et al. 2009. “MEDULLARY PAIN FACILITATING NEURONS MEDIATE ALLODYNIA IN HEADACHE-RELATED PAIN.” Annals of neurology 65 (2): 184-93. https://doi.org/10.1002/ana.21537. Eippert, Falk, Ulrike Bingel, Eszter D. Schoell, Juliana Yacubian, Regine Klinger, Jürgen Lorenz, and Christian Büchel. 2009. “Activation of the Opioidergic Descending Pain Control System Underlies Placebo Analgesia.” Neuron 63(4): 533‑43. https://doi.org/10.1016/j.neuron.2009.07.014. Goadsby, Peter J., Philip R. Holland, Margarida Martins-Oliveira, Jan Hoffmann, Christoph Schankin, and Simon Akerman. 2017. “Pathophysiology of Migraine: A Disorder of Sensory Processing”. Physiological Reviews 97(2): 553-622. https://doi.org/10.1152/physrev.00034.2015. Goadsby, PJ, and JW Duckworth. 1989. “Low Frequency Stimulation of the Locus Coeruleus Reduces Regional Cerebral Blood Flow in the Spinalized Cat.” Brain Research 476 (1): 71-77. https://doi.org/10.1016/0006-8993(89)91537-0. Hoffmann, Jan, Weera Supronsinchai, Simon Akerman, Anna P. Andreou, Christopher J. Winrow, John Renger, Richard Hargreaves, and Peter J. Goadsby. 2015. “Evidence for Orexinergic Mechanisms in Migraine”. Neurobiology of Disease 74 (February): 137-43. https://doi.org/10.1016/j.nbd.2014.10.022. Holland, Philip, and Peter J. Goadsby. 2007. “The Hypothalamic Orexinergic System: Pain and Primary Headaches.” Headache 47 (6): 951-62. https://doi.org/10.1111/j.1526-4610.2007.00842.x. Hosobuchi, Y., JE Adams, and R. Linchitz. 1977. “Pain Relief by Electrical Stimulation of the Central Gray Matter in Humans and Its Reversal by Naloxone.” Science (New York, NY) 197 (4299): 183-86. https://doi.org/10.1126/science.301658. Maniyar, Farooq Husain, Till Sprenger, Teshamae Monteith, Christoph Schankin, and Peter James Goadsby. 2014. “Brain Activations in the Premonitory Phase of Nitroglycerin-Triggered Migraine Attacks.” Brain 137 (1): 232‑41. https://doi.org/10.1093/brain/awt320. May, Arne, and Rami Burstein. 2019. “Hypothalamic Regulation of Headache and Migraine”. Cephalalgia 39 (13): 1710‑19. https://doi.org/10.1177/0333102419867280. Moulton, Eric A., Lino Becerra, Adriana Johnson, Rami Burstein, and David Borsook. 2014. “Altered Hypothalamic Functional Connectivity with Autonomic Circuits and the Locus Coeruleus in Migraine.” Edited by Daniele Marinazzo. PLoS ONE 9 (4): e95508. https://doi.org/10.1371/journal.pone.0095508. Osipov, Michael H., Gregory O. Dussor, and Frank Porreca. 2010. “Central Modulation of Pain.” Journal of Clinical Investigation 120(11): 3779-87. https://doi.org/10.1172/JCI43766. Reynolds, DV 1969. “Surgery in the Rat during Electrical Analgesia Induced by Focal Brain Stimulation”. Science (New York, NY) 164 (3878): 444-45. https://doi.org/10.1126/science.164.3878.444. Richardson, DE, and H. Akil. 1977. “Long Term Results of Periventricular Gray Self-Stimulation”. Neurosurgery 1 (2): 199-202. https://doi.org/10.1097/00006123-197709000-00018. Sasa, M, and S Takaori. 1973. “Influence of the Locus Coeruleus on Transmissioa in the Spinal Trigeminal Nucleus Neurons,” 6. Schwarz, Lindsay A., and Liqun Luo. 2015. “Organization of the Locus Coeruleus-Norepinephrine System.” Current Biology 25 (21): R1051-56. https://doi.org/10.1016/j.cub.2015.09.039. Takano, Takahiro, Guo-Feng Tian, ​​Weiguo Peng, Nanhong Lou, Ditte Lovatt, Anker J Hansen, Karl A Kasischke, and Maiken Nedergaard. 2007. “Cortical Spreading Depression Causes and Coincident with Tissue Hypoxia”. Nature Neuroscience 10(6): 754-62. https://doi.org/10.1038/nn1902. Tassorelli, Cristina, and Shirley A. Joseph. 1995. “Systemic Nitroglycerin Induces Fos Immunoreactivity in Brainstem and Forebrain Structures of the Rat.” Brain Research 682 (1-2): 167-81. https://doi.org/10.1016/0006-8993(95)00348-T. Ter Horst, Gj, Wj Meijler, J Korf, and Rha Kemper. 2001. “Trigeminal Nociception-Induced Cerebral Fos Expression in the Conscious Rat.” Cephalalgia 21 (10): 963-75. https://doi.org/10.1046/j.1468-2982.2001.00285.x. Tsou, K., and CS Jang. 1964. “Studies on the Site of Analgesic Action of Morphine by Intracerebral Micro-Injection”. Scientia Sinica 13 (July): 1099‑1109. Voisin, DL, N Guy, M Chalus, and R Dallel. 2005. “Nociceptive stimulation activates locus coeruleus neurons projecting to the somatosensory thalamus in the rat”. The Journal of Physiology 566 (Pt 3): 929-37. https://doi.org/10.1113/jphysiol.2005.086520.

Plus d'articles

Retours au blog

Vous avez encore plein d'articles à découvrir !